BioSpace News Archive

Business

BioAge Makes A Big Bet on Amgen Drug To Target Muscle Aging

BGE-105 (formerly AMG 986) mimics the production of apelin, a peptide that has been found in animal studies to improve muscle regeneration and decrease mouse frailty.

April 15, 2021
·
3 min read
·
Heather McKenzie
Drug Development

GSK Halts Two Mid-Stage Studies of ICOS Agonist Feladilimab

GlaxoSmithKline halted two mid-stage studies assessing feladilimab combined with Merck’s Keytruda as a potential treatment in different oncology settings.

April 15, 2021
·
2 min read
·
Alex Keown
Biotech Beach

Medable Raises $194 Million In a Year to Push Digital Clinical Trials

Software company Medable raised a $78 million extension on its Series C round–totaling $194 million in venture funding over three raises in the past year–to tap the growing opportunity in decentralized digital clinical trials.

April 15, 2021
·
2 min read
·
Mark Zipkin
Business

Pfizer CEO: Third COVID-19 Vaccine Dose Will Likely Be Needed Within 12 Months

Although the data is not there, Pfizer’s chief executive officer, Albert Bourla, recently said he thought people will “likely” need a booster dose of a vaccine within 12 months of getting fully vaccinated. It’s possible, he also said, they will need to be vaccinated annually.

April 15, 2021
·
2 min read
·
Mark Terry
Genetown

Research Roundup: UK Variant Not as Lethal as Originally Reported and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

April 15, 2021
·
5 min read
·
Mark Terry
Drug Development

Inovio’s DNA Vaccine Generates Robust Responses Against COVID-19 Variants in Study

Shares of Inovio are climbing in early trading this morning after the company announced its DNA vaccine candidate for COVID-19 induced a robust T-cell response against multiple variants of the SARS-CoV-2 virus.

April 15, 2021
·
3 min read
·
Alex Keown
Pharm Country

Merck Ditches $425 Million COVID-19 Drug, Refocusing on Another Candidate

This marks another setback for Merck in the battle against COVID-19 after it shuttered its pandemic vaccine program in January following poor responses in Phase I studies.

April 15, 2021
·
2 min read
·
Alex Keown
Policy

COVID-19 Infection After Vaccine is Rare But Possible, CDC Says

The U.S. CDC said up to 5,800 people who have been fully vaccinated against coronavirus disease 2019 (COVID-19) have been infected by the novel coronavirus following vaccination.

April 15, 2021
·
3 min read
·
Brandon May
Post-Pandemic Analysis: How Will Work-from-Home Workplace Styles Look in the Future?

As the world adapts to a new normal, here are a few new concepts that will be a part of work-from-home workplaces in the future.

April 15, 2021
·
2 min read
·
Brandi Marcene
Policy

FDA Needs More Data to Decide on J&J Vaccine Clotting Problem

The U.S. FDA’s Advisory Committee on Immunization Practices (ACIP) met yesterday to make a recommendation on the current pause of the Johnson & Johnson COVID-19 vaccine.

April 15, 2021
·
5 min read
·
Mark Terry